DK170016B1 - Præparat med kontrolleret afgivelse af det aktive stof - Google Patents

Præparat med kontrolleret afgivelse af det aktive stof Download PDF

Info

Publication number
DK170016B1
DK170016B1 DK464686A DK464686A DK170016B1 DK 170016 B1 DK170016 B1 DK 170016B1 DK 464686 A DK464686 A DK 464686A DK 464686 A DK464686 A DK 464686A DK 170016 B1 DK170016 B1 DK 170016B1
Authority
DK
Denmark
Prior art keywords
composition according
isradipine
composition
administration
release
Prior art date
Application number
DK464686A
Other languages
Danish (da)
English (en)
Other versions
DK464686D0 (da
DK464686A (da
Inventor
Othmar Zueger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK464686D0 publication Critical patent/DK464686D0/da
Publication of DK464686A publication Critical patent/DK464686A/da
Application granted granted Critical
Publication of DK170016B1 publication Critical patent/DK170016B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK464686A 1985-10-01 1986-09-29 Præparat med kontrolleret afgivelse af det aktive stof DK170016B1 (da)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
GB8524135 1985-10-01
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB8524653 1985-10-07
GB8531419 1985-12-20
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB8603097 1986-02-07
GB8605037 1986-02-28
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (3)

Publication Number Publication Date
DK464686D0 DK464686D0 (da) 1986-09-29
DK464686A DK464686A (da) 1987-04-02
DK170016B1 true DK170016B1 (da) 1995-05-01

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464686A DK170016B1 (da) 1985-10-01 1986-09-29 Præparat med kontrolleret afgivelse af det aktive stof

Country Status (20)

Country Link
KR (1) KR920008817B1 (de)
AT (1) AT402257B (de)
BE (1) BE905516A (de)
CA (1) CA1298784C (de)
CH (1) CH669524A5 (de)
DE (1) DE3632201C2 (de)
DK (1) DK170016B1 (de)
ES (1) ES2002508A6 (de)
FR (1) FR2589732B1 (de)
GR (1) GR862457B (de)
HK (1) HK392A (de)
HU (1) HU197201B (de)
IE (1) IE59589B1 (de)
IL (1) IL80182A (de)
LU (1) LU86615A1 (de)
NL (1) NL194822C (de)
NZ (1) NZ217732A (de)
PT (1) PT83456B (de)
SE (1) SE503222C2 (de)
SG (1) SG103391G (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
ATE409475T1 (de) * 2001-02-20 2008-10-15 Dinan Timothy Gerard Behandlung von fibromyalgie mit pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
AU4064285A (en) * 1984-03-21 1985-10-11 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
KR870003777A (ko) 1987-05-04
SG103391G (en) 1992-01-17
KR920008817B1 (ko) 1992-10-09
IE59589B1 (en) 1994-03-09
SE503222C2 (sv) 1996-04-22
IL80182A (en) 1991-01-31
NL194822C (nl) 2003-04-03
IE862565L (en) 1987-04-01
HK392A (en) 1992-01-10
ES2002508A6 (es) 1988-08-16
FR2589732B1 (fr) 1989-07-13
NZ217732A (en) 1990-07-26
DE3632201A1 (de) 1987-04-02
NL8602370A (nl) 1987-05-04
FR2589732A1 (fr) 1987-05-15
CA1298784C (en) 1992-04-14
SE8604112L (sv) 1987-04-02
HUT44701A (en) 1988-04-28
GR862457B (en) 1987-01-29
DK464686D0 (da) 1986-09-29
ATA260486A (de) 1996-08-15
PT83456A (en) 1986-10-01
HU197201B (en) 1989-03-28
LU86615A1 (fr) 1987-04-02
AT402257B (de) 1997-03-25
CH669524A5 (de) 1989-03-31
PT83456B (pt) 1989-05-12
DE3632201C2 (de) 1997-05-07
IL80182A0 (en) 1986-12-31
NL194822B (nl) 2002-12-02
SE8604112D0 (sv) 1986-09-29
DK464686A (da) 1987-04-02
BE905516A (fr) 1987-03-30

Similar Documents

Publication Publication Date Title
DK173033B1 (da) Farmaceutisk præparat med forlænget frigørelse og fremstilling deraf
JP4108980B2 (ja) 持続放出ラノラジン製剤
US20110177168A1 (en) Composition
AU2001260212A1 (en) Composition
US5399360A (en) Pharmaceutical compositions
CN115518066A (zh) 一种用于治疗抗凝血的药物组合物及应用
GB2154874A (en) Bromocriptine compositions
DK167138B1 (da) Farmaceutiske praeparater indeholdende ergotalkaloider
DK170016B1 (da) Præparat med kontrolleret afgivelse af det aktive stof
GB2181053A (en) Controlled release formulation
ITMI970047A1 (it) Composizione farmaceutica antitubercolare e procedimento per la sua produzione
US5069911A (en) Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
US6531458B1 (en) Stable compositions comprising levosimendan and alginic acid
AU618599B2 (en) Controlled release bromocriptine formulations
AU598751B2 (en) Pharmaceutical formulations with controlled release of the active substance
KR102267965B1 (ko) 베타 차단제, 전환 효소 억제제 및 항고혈압제 또는 nsaid를 포함하는 약학적 조성물
CZ20002675A3 (cs) Tiagabinové prostředky s prodlouženým uvolňováním se sníženými vedlejšími účinky
JPS62149618A (ja) 活性物質放出制御医薬製剤

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired